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Atherosclerosis is a complex inflammatory pathology underpinning cardiovascular
diseases (CVD), which are the leading cause of death worldwide. The interplay
between vascular stromal cells and immune cells is fundamental to the progression
and outcome of atherosclerotic disease, however, the majority of in vitro studies do
not consider the implications of these interactions and predominantly use mono-culture
approaches. Here we present a simple and robust methodology involving the co-culture
of vascular endothelial (ECs) and smooth muscle cells (SMCs) alongside an inflammatory
compartment, in our study containing THP-1 macrophages, for studying these complex
interactions. Using this approach, we demonstrate that the interaction between vascular
stromal and immune cells produces unique cellular phenotypes and soluble mediator
profiles not observed in double-cell 2D cultures. Our results highlight the importance of
cellular communication and support the growing idea that in vitro research must evolve
from mono-culture systems to provide data more representative of the multi-cellular
environment found in vivo. The methodology presented, in comparison with established
approaches, has the advantage of being technically simple whilst enabling the isolation
of pure populations of ECs, SMCs and immune cells directly from the co-culture without
cell sorting. The approach described within would be applicable to those studying
mechanisms of vascular inflammation, particularly in relation to understanding the impact
cellular interaction has on the cumulative immune-vascular response to atherogenic or
inflammatory stimuli.
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INTRODUCTION
Despite global efforts to prevent and treat cardiovascular diseases, myocardial infarction and
stroke remain leading causes of mortality worldwide (1, 2). The common pathological link
between these clinical outcomes is atherosclerosis, a progressive inflammatory disease of the
arteries (3–5). The predominant cellular components of arteries are vascular endothelial (ECs) and
smooth muscle cells (SMCs), both of which play key roles in the development of atherosclerosis.
EC dysfunction develops in response to perturbations of normal blood flow combined with
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risk factors such as hypercholesterolemia (6, 7). In parallel, SMCs
undergo phenotypic changes, paradoxically contributing to both
the structural stabilization of atherosclerotic lesions but at the
same time enhancing local inflammation (8). Equally, immune
responses play a key role in atherosclerosis. The recruitment
of monocytes by activated ECs and their differentiation into
inflammatory macrophages in the tissue represents a hallmark
of the disease (9, 10). As pathology progresses the contribution
of immune cells to atherosclerotic plaque composition increases,
with the formation of arterial tertiary lymphoid organs (11–13).
Increasing understanding of immune cell heterogeneity in
atherosclerotic lesions, using single cell RNA sequencing and
Time of Flight Mass Cytometry (14, 15) supports the need
to study interactions of defined subsets of immune cells with
endothelial and vascular smooth muscle cells in detail. However,
this is hard to address in vivo. Given the huge complexity
of atherosclerotic disease and the interplay between stromal
and immune cells, the use of co-culture systems has been
identified as an important and advantageous approach to in vitro
research (16). Several vascular-immune co-culture models have
been published to date (16–21). However, whilst these models
are certainly useful, they often suffer from being technically
demanding, for example requiring custom culture scaffolds
or perfusion equipment. Given this limitation, we aimed to
develop a simplified in vitro co-culture approach for studying
the cumulative response of key vascular cells alongside a flexible
immune/inflammatory compartment.
Here we describe a triple-compartment cell culture model
comprising of ECs, SMCs and an immune/inflammatory
component, which in this study consisted of THP-1
macrophages. This model has the advantage of being technically
simple whilst allowing for the independent isolation of each
cellular compartment for downstream analysis without cell
sorting. Moreover, this model could be further customized and




Human coronary artery endothelial cells (ECs) and human
coronary artery smooth muscle cells (SMCs) were purchased
from PromoCell (Heidelberg, Germany; lot numbers 4071602
and 4082801.2, respectively), and used between passage six and
nine for all experiments. All vascular cell culture media used
was purchased from PromoCell and are detailed in Table 1.
Monocultures of all vascular cells were maintained in 75 cm2
tissue culture treated vented flasks (Corning, NY, USA) in a 37◦C
and 5% CO2 environment in the appropriate media.
THP-1 monocytes/macrophages were maintained in RPMI
media (Thermo Fisher Scientific, Paisley, UK) supplemented
with 10% fetal calf serum (FCS; Thermo Fisher Scientific,
Inchinnan, UK), L-glutamine (Thermo Fisher Scientific),
and Penicillin/Streptomycin (Sigma Aldrich, Dorset, UK).
Monocultures of THP-1 were maintained in 75 cm2 tissue
culture treated vented flasks (Corning) in a 37◦C 5% CO2
environment. The differentiation of THP-1 monocytes to
TABLE 1 | Cell culture media and supplements.
Cells in culture Product name (supplement components)
Endothelial cell
monoculture
Endothelial cell growth medium
(Fetal calf serum (0.02 mL/mL), Endothelial Cell Growth
Supplement/ECGS (0.004 mL/mL), human recombinant
epidermal growth factor (0.1 ng/mL), human
recombinant basic fibroblast growth factor (1 ng/mL),




Smooth muscle cell growth medium 2
(Fetal calf serum (0.05 mL/mL), human recombinant
epidermal growth factor (0.5 ng/mL), human
recombinant fibroblast growth factor (2 ng/mL), human
recombinant insulin (5µg/mL), penicillin, streptomycin.
Co-culture Smooth muscle cell growth medium 2 + ECGS
(media contains all supplements listed in SMC
monoculture, with the addition of bovine hypothalamic
extract (12µg/mL) and heparin (45µg/mL).
adherent macrophage-like cells was achieved by stimulating
1 × 106 THP-1 monocytes with 100 ng/mL phorbol 12-
myristate 13-acetate (PMA) for 72 h in 6 well tissue culture
treated plates (Corning).
The Triple-Cell Co-culture Methodology
Atherosclerosis co-cultures were maintained in a 37◦C and 5%
CO2 environment. SMCs were seeded at a density of 3–5 × 104
cells/cm2 on the underside of Geltrex (Thermo Fisher Scientific)
coated 0.4 or 3µm pore 6 well transwell inserts (Corning). This
was achieved by inverting the entire plate containing the insert.
The bottom of the plate was then removed leaving the inserts
inverted standing on the lid of the plate. SMCs were then seeded
in a small volume of SMC monoculture media (200 µl for six
well plate) on the bottom of the insert. The bottom of the culture
plate was then placed back on top of the inserts; when placing the
plate back on top of the inserts the droplet of media will spread
to cover the majority of the insert. The SMCs were then allowed
to adhere to the transwell membrane for 1 h at 37◦C and 5%
CO2. The plate was then reoriented and 2mL SMC monoculture
media was gently added into the well with 1mL then added on
top of the insert. Inserts remained in culture until SMCs reached
confluence, with media changed every 2–3 days. Following this,
inserts were transferred to a new six well plate containing fresh
co-culture media. ECs in co-culture media were then seeded at
confluent density (4 × 104 cells/cm2) on the upper surface of
the transwell inserts and rested for 24 h. Immune compartments
were prepared accordingly to ensure they were ready for use
following the 24 h rest period. In our case, THP-1 macrophages
were differentiated in separate six well plates as described above;
when required for use in the co-culture system THP-1 were
stimulated with 100 ng/mL LPS for 2 h to enhance cytokine
production (22, 23), washed thoroughly to remove any residual
LPS, and wells filled with co-culture media. Co-culture inserts
were then transferred into wells containing differentiated THP-
1. For all experiments EC+THP-1, SMC+THP-1, EC+SMC, and
EC+SMC+THP-1 co-cultures were cultured in co-culture media
for the same duration.
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Isolation of Co-culture Cell Layers
ECs were isolated from cultures first by mechanical disruption
using a rubber syringe plunger, and carefully removed from the
transwell insert and transferred to a suitable vessel using a pipette.
Transwells were then transferred to a separate plate containing
ice-cold PBS. To remove SMCs, transwells were held at an angle
in a fresh recipient well containing ice-cold PBS, SMC layers were
mechanically disrupted using a cell scraper and the bottom of
the transwell was washed thoroughly to ensure all SMCs were
removed into the well. SMCs were then transferred into a suitable
vessel. THP-1 cells were isolated last from the bottom of the plates
via mechanical disruption with a cell scraper and transferred to a
suitable vessel.
Immunofluorescent Imaging of Co-culture
Inserts
Co-culture inserts were fixed in 4% Paraformaldehyde, blocked
using Dako serum free protein block and then fluorescently
labeled with anti-α smooth muscle cell actin (αSMA) conjugated
to FITC (Sigma, Dorset, UK; Cat# F3777) for the identification of
SMCs and anti-CD31 conjugated to Alexa-Fluor 594 (Biolegend,
London, UK; Cat# 303126) for the identification of ECs.
Images were acquired using a Zeiss Cell Observer SD (Zeiss,
Jena, Germany) equipped with a Yokagawa CSU-X1 spinning
disk system.
Western Blot
Each cell layer was isolated as described above; proteins were
extracted from cells using RIPA lysis buffer (50mM Tris-
HCl, 150mM NaCl, 0.25% Sodium Deoxycholate, 1mM EDTA,
1% Nonidet P-40 with protease and phosphatase inhibitors;
ThermoFisher Scientific). Samples were resolved on precast 4–
20% SDS/PAGE Gels (Expedeon, CA, USA) and transferred
to nitrocellulose membranes prior to immunoblotting with
antibodies against endothelial nitric oxide synthase (eNOS; R&D
Systems, Abingon, UK; Cat# AF950), α-SMA (Agilent, CA, USA;
Clone 1A4), and CD11b (R&D systems, Cat# MAB16992). Anti-
goat- (Cat# HAF017; R&D systems) and anti-mouse- (Cat#
NA931V; GE Healthcare, IL, USA)—HRP secondary antibodies
were used as required. Blots were visualized using a Licor C-DiGit
(Licor, NE, USA) and Advansta WesternBright ECL (Advansta,
CA, USA).
Quantitative Real-Time Reverse
Transcription Polymerase Chain Reaction
(qRT-PCR)
Each cell layer was isolated as described above; cells were
then centrifuged, and cell pellets resuspended in qiazol lysis
reagent (Cat# 79306; Qiagen, Manchester, UK). Total RNA was
extracted from ECs and SMCs using the miRNeasy mini kit
(Qiagen, Manchester, UK) following manufacturer’s instructions.
For mRNA analysis, RNA was reverse transcribed using the
Taqman R© Reverse Transcription Kit (ThermoFisher Scientific)
and random hexamer primers according to manufacturer’s
instructions. qPCR reactions were performed using Taqman R©
mastermix, primers and probes on a Quantstudio 12K
flex real-time PCR system (ThermoFisher Scientific). Each
reaction contained 1X TaqMan R© Mastermix, 1X cDNA probe
(GAPDH: Hs02786624_g1/ NOS3: Hs01574665_m1/VCAM1:
Hs01003372_m1/ CDH5: Hs00901465_m1/ PCNA:
Hs00427214_g1/ ACTA2: Hs00426835_g1/ CNN:
Hs00959434_g1/ TAGLN: Hs01038777_g1 - all ThermoFisher
Scientific) and 1.5 µL RT product in a total volume of 10 µL.
Real-time PCR was performed at 95◦C for 10min, followed by
40 cycles of 95◦C for 15 s and 60◦C for 1min. All PCRs were
performed in duplicate wells per plate. The threshold cycle (Ct)
was used to determine the relative quantities of each mRNA.
Measurements were normalized to the housekeeper UBC (1Ct)
and the inverse log of 11Ct gave the relative fold change
(denoted as RQ).
Analysis of Soluble Inflammatory
Mediators
Following 24 h of co-culture, supernatants were isolated from
double and triple-cell cultures and centrifuged at 10,000 g for
10min to remove particulates. The remaining supernatant was
then assessed for concentrations of E-selectin, granulocyte-
macrophage colony-stimulating factor (GM-CSF), interferon-α
(IFN-α), IFN-γ, interleukin (IL)-1α, IL-1β, IL-10, IL-12p70, IL-
13, IL-17A, IL-4, IL-6, IL-8, IP-10, monocyte chemoattractant
protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-
1α), MIP-1β, P-selectin, soluble intercellular adhesion molecule-
1 (sICAM-1) and tumor necrosis factor-α (TNF-α), using a
20-plex human cytokine assay according to the manufacturer’s
instructions (ThermoFisher Scientific) and analyzed on a Bio-
plex 200 Luminex system (Bio-Rad Laboratories Ltd). Data was
analyzed using Bio-Plex 6.1 software with 5PL curve fitting.
Statistical Analysis
Data are presented as mean± standard error of the mean (SEM).
One-way ANOVA or repeated measures one-way ANOVA with
Tukey’s post-hoc tests were performed to determine significance
between groups; statistical analyses of qPCR data were performed
on 1Ct values. Significance was set at P < 0.05. All statistical
analyses were performed using GraphPad Prism v.8 (GraphPad
Software, USA).
RESULTS AND DISCUSSION
It is well recognized that the interplay between ECs, SMCs and
the immune system is central to the progression and outcome
of cardiovascular disease and atherosclerosis (3, 5, 11). However,
in vitro mechanistic experiments performed in cell culture often
lack this critical element. Consequently, in order to generate
in vitro data of high relevance to the complexity of human
atherosclerosis, the use of vascular-immune co-cultures has been
explored. Here we have described the development of a modular
co-culture system which facilitates the separation of each cellular
compartment in a technically simple manner that avoids the
use of cell sorting, which can modify cell properties in an
untoward way.
Several models utilizing the co-culture of ECs, SMCs and
macrophages have been published (16). Predominantly these
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models use at least one aspect of direct cellular contact, whereby
different cell types are cultured sequentially to provide confluent
layers stacked on top of one another (24). Alternatively, some
models separate one cellular layer using a transwell membrane
system (16, 25). In some cases these direct contact models are
highly advanced, for example, Mallone and colleagues developed
a spheroid model of atherosclerotic plaque comprising of human
myofibroblasts and peripheral blood mononuclear cells (PBMC)
(26). The use of PBMCs in this model was highly advantageous,
producing spheroid “plaques” with a heterogeneous population
of immune cells suitable for investigation. In contrast, Robert
and colleagues developed an approach involving the seeding of
tubular scaffolds with human myofibroblasts, which were then
cultured under flow and subsequently seeded with endothelial
cells to produce highly arterial-like in vitro vessels (20). The
authors demonstrated the potential of this model by briefly
exploring the response to atherogenic low-density lipoproteins
and macrophage adhesion/transmigration in the cultured vessel.
However, whilst both of these models have clear utility, they also
have some limitations; both models lack bona fide SMCs, whilst
the model described by Mallone and colleagues also lacks ECs.
Importantly, both approaches would require cell sorting in order
to isolate each cell type for classical molecular analyses such as
Western Blotting and qRT-PCR.
Here we have developed a triple-cell 2D model of the
atheroma which facilitates the interaction of immune cells with
a vascular compartment via soluble mediators, whilst allowing
the pure isolation of each cellular layer without a need for cell
sorting. To achieve our aims, SMCs were seeded on the underside
of transwell inserts and cultured until confluent. In parallel,
THP-1 monocytes were differentiated into macrophage-like cells
using PMA. When SMCs reached confluence ECs were seeded
on the upper side of transwell inserts and allowed to adhere for
24 h. Inserts were then transferred into plates containing LPS
stimulated adherent macrophage-like THP-1 cells. A diagram of
this process is shown in Figure 1.
We first carried out immunofluorescence staining of transwell
inserts seeded with SMCs and ECs prior to transfer into
THP-1 containing plates. CD31 and αSMA staining of 0.4µm
pored transwell inserts identified confluent populations of
SMCs and ECs separated by the thin transwell membrane
(Figure 2A). We next confirmed that each cell population was
free from contamination by the other cell types. ECs were
isolated from confluent EC/SMC/THP-1 co-cultures first by
mechanical disruption using a rubber syringe plunger, and
carefully removed from the transwell insert and transferred to
a suitable vessel. Transwells were then transferred to a separate
plate containing ice-cold PBS filled wells. To remove SMCs,
transwells were held at an angle in the recipient well, SMC
layers were mechanically disrupted using a cell scraper and
the bottom of the transwell washed thoroughly to ensure all
SMCs were removed. THP-1 cells adhering to the base of the
FIGURE 1 | Schematic of triple-cell 2D co-culture methodology. Vascular smooth muscle cells (SMCs) were cultured on the underside of transwell inserts by inverting
the entire plate. Once confluent vascular endothelial cells (ECs) were cultured on the upper side. This EC/SMC co-culture was then added to an immune
compartment, in this case PMA differentiated THP-1 monocytes.
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FIGURE 2 | Triple-cell co-culture provides pure cellular niches for macrophages, vascular endothelial and vascular smooth muscle cells. (A) Prior to completion of
co-cultures via the addition of THP-1 cells, EC/SMC coated transwell inserts were analyzed via immunofluorescent microscopy for CD31 (red) and αSMA (green).
Scale Bars = 40µm. Following completion of EC/SMC/THP-1 co-cultures using both 0.4µm (B) and 3µm (C) transwell inserts, cells were isolated from each cellular
niche and analyzed by immunoblotting for eNOS, αSMA, and CD11b. n = 3 co-cultures. (D) SMC were cultured on the underside of 3µm transwell inserts and 3
days later analyzed by immunofluorescent microscopy for the expression of αSMA (green). (E) ECs or SMCs were cultured on 0.4µm inserts until confluent. They
were then mechanically disrupted and analyzed for viability using trypan blue exclusion. n = 6 cultures. Scale Bar = 10µm.
coculture plates were also isolated via mechanical disruption
with a cell scraper. Mechanical disruption is commonly used
to isolate macrophages, but not SMCs and ECs. To ensure
this was not an issue for these cell types we carried out
analysis of viability using trypan blue staining. Here, we found
viabilities of ∼90% and ∼80% for ECs and SMCs, respectively,
confirming this method of isolation did not significantly
compromise the isolated cells (Figure 2E). Once each layer
was isolated Western Blot analysis was conducted for eNOS,
αSMA, and CD11b, used to discriminate ECs, SMCs, and THP-1,
respectively. Co-cultures using 0.4µm pored inserts yielded pure
cell populations, with no evident contamination between layers
from adjacent cell types and confirming the ability to individually
isolate each culture layer (Figure 2B). Contrastingly, the use
of 3µm inserts allowed for the migration of SMCs through
into the EC layer and vice versa (Figure 2C). We confirmed
this observation by seeding SMCs on the underside of 3µm
transwell inserts and 3 days later carried out immunofluorescent
microscopy for αSMA to identify if SMCs could migrate from
the bottom to the top of the insert. As expected, we found
SMCs on both sides of the transwell membrane (Figure 2D).
Consequently, if mixed EC/SMC populations were desired to
facilitate direct cellular contact this would be possible using
3 µm inserts.
We next aimed to confirm that the culture of ECs and
SMCs together with an “immune” compartment in 2D produced
biologically relevant changes to the phenotype of the cells
in our model in comparison with equivalent double-cell 2D
cultures. It is known that the culture of ECs with SMCs in
non-inflammatory conditions increases eNOS expression (27).
We found that ECs from EC/SMC co-cultures displayed a
trend toward increased eNOS expression in comparison to
EC/THP-1 co-cultures, though this did not reach significance
(Figure 3Ai). Interestingly, we observed that the co-culture
of ECs, SMCs, and THP-1 together induced a significant
repression of EC eNOS, suggesting that triple-cell co-culture
enhances the impact of inflammation on EC phenotype. We
next investigated the expression of CDH5; CDH5 encodes VE-
cadherin, which contributes to the integrity of intercellular
junctions and endothelial permeability. We found that triple-cell
co-cultured ECs hadCDH5 levels similar to those of ECs cultured
with THP-1 alone (Figure 3Aii). However, we also noted that
EC/THP-1 co-cultures displayed significantly reduced CDH5
when compared with EC/SMC cultures. ECs from triple-cell
cultures also showed a trend toward reduced CDH5 expression
in comparison with EC/SMC cultures, though this did not reach
significance. Therefore, our results suggest that EC/SMC co-
cultures have increased EC junction integrity in comparison
with cultures containing an inflammatory compartment, as one
might expect. We found expression of the proliferation marker
PCNA to be reduced in ECs exposed to THP-1, irrespective of
the presence of SMCs (Figure 3Aiii). Furthermore, we identified
a small but significant increase in platelet endothelial cell
adhesionmolecule 1 (PECAM-1) in EC/THP-1 vs EC/SMC/THP-
1 (Figure 3Aiv) alongside a striking increase in vascular cell
adhesion molecular 1 (VCAM-1) in triple-cell cultured ECs
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FIGURE 3 | Altered cellular phenotype by macrophage, vascular endothelial and vascular smooth muscle cell interaction. ECs were co-cultured with THP-1, SMCs, or
both THP-1 and SMCs simultaneously. Twenty-Four hours following co-culture each cell type was isolated from culture and analyzed via RT-qPCR for the expression
of (Ai) eNOS, (Aii) CDH5, (Aiii) PCNA, (Aiv) PECAM-1, and (Av) VCAM-1. SMCs were co-cultured with THP-1, ECs, or both THP-1 and ECs simultaneously, and
analyzed for the expression of (Bi) ACTA2, (Bii) CNN1, and (Biii) TAGLN. Results were analyzed by one-way ANOVA with Tukey’s multiple comparisons test.
*P < 0.05, **P < 0.01, ***P < 0.001. n = 4–6 co-cultures.
when compared to both double-cell 2D conditions (Figure 3Av).
The increase in VCAM-1 is particularly interesting. VCAM-1
is an adhesion molecule fundamental to the recruitment of
immune cells and has been identified as a potentially useful
biomarker for molecular imaging in cardiovascular disease
(28). Its significant upregulation by the presence of SMCs and
THP-1, but not either cell type alone, highlights a role for
the multi-directional communication between ECs, SMCs and
macrophages in modulating adhesion molecule expression. In
addition to analyzing ECs, we also investigated the expression
of smooth muscle α-actin (ACTA2), calponin 1 (CNN1), and
transgelin (TAGLN) in SMCs from SMC/THP-1, EC/SMC, and
EC/SMC/THP-1 co-cultures. Expression of all three markers
is associated with a contractile SMC phenotype (29). No
differences in TAGLN were observed between co-cultures,
however we did identify a decrease in ACTA2 expression
in the SMC/THP-1 and EC/SMC/THP-1 co-cultures when
compared with EC/SMC co-cultures (Figure 3B). Furthermore,
we identified a significant decrease in CNN1 expression between
the EC/SMC/THP-1, but not SMC/THP-1, when comparing
with EC/SMC co-cultures (Figure 3B). This data suggests a less
contractile smooth muscle phenotype in cultures containing
THP-1, consistent with previous studies showing that acquisition
of a pro-inflammatory SMC phenotype is associated with
downregulation of SMC contractile genes (30). Whist further
analysis would be required to clarify the full phenotypic
impact of the triple-cell co-culture on SMCs, the data again
highlights the possibility to isolate individual cell types from this
culture system and carry out further analyses. The distribution
of 1CT values for all data in Figure 3 is presented in
Supplemental Figure 1.
Finally, we utilized Luminex to quantify the expression
of soluble mediators from the supernatants from EC/THP-1,
SMC/THP-1, EC/SMC, and EC/SMC/THP-1 co-cultures. In this
comparison we present data from the analysis of TNF-α, IL-
1β, IL-10, E-selectin, sICAM-1, and GM-CSF (Figure 4). We
found significant differences in these molecules in between at
least two co-culture models. We identified that E-selectin was
only detectable when co-cultures contain both ECs and THP-1
but was not dependent on the presence of SMCs. Furthermore,
Frontiers in Immunology | www.frontiersin.org 6 April 2019 | Volume 10 | Article 849
Noonan et al. A Triple-Compartment in vitro Model of Vascular Inflammation
FIGURE 4 | Soluble mediator profile of macrophage, vascular endothelial and vascular smooth muscle cell co-cultures. EC/THP-1, SMC/THP-1, EC/SMC, and
EC/SMC/THP-1 co-cultures were prepared. Twenty-four hours later co-culture supernatants were collected and analyzed for the presence of TNF-α, IL-1β, IL-10,
E-selectin, sICAM-1, and GM-CSF by Luminex. Results were analyzed by one-way ANOVA with Tukey’s multiple comparisons test. *P < 0.05, **P < 0.01,
***P < 0.001, ****P < 0.0001. n = 6 co-cultures. <LLQ, less than Lower Limit of Quantification.
we found that the production of TNF-α, IL-1β, IL-10, sICAM-1,
and GM-CSF appeared reliant on the presence of themacrophage
compartment, and thus an inflammatory stimulus. Whilst
the production of these molecules was dependent on THP-
1, we did find significant differences between our triple-
cell and the comparative THP-1 containing double cell co-
cultures. Most interestingly, we found our triple-cell culture
had a mildly, but significantly, blunted TNF-alpha response
in comparison with EC/THP-1 and SMC/THP-1 cultures, and
significantly increased GM-CSF production. This data again
highlights the importance of utilizing more advanced co-culture
methodologies, such as our triple-cell 2D model, over similar
double cell cultures.
In summary, the observation that EC/SMC/THP-1 triple-
cell 2D cultures create a significantly different phenotype in
respect to both soluble mediators and cell surface molecules,
when compared to double-cell cultures, underscores the
utility and potential of our approach for the study of
key vascular-inflammatory mechanisms in the context of
multi-cellular communication.
CONCLUSIONS
We have developed a co-culture model for the study of the
immune-vascular interplay in atherosclerosis consisting of ECs,
SMCs and an inflammatory compartment. In order to validate
this model, we have demonstrated that the triple-cell 2D culture
of ECs, SMCs, and THP-1 macrophage-like cells significantly
alters the phenotype of ECs and SMCs within this culture in
comparison with EC/SMC, EC/THP-1, or SMC/THP-1 double-
cell cultures. Our results are indicative of the multi-directional
communication between highly plastic vascular stromal cells and
the immune system, which is now well recognized in the field,
and highlight the applicability of this model for investigating
cumulative immune-vascular responses in vitro. In order to
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increase the relevance of in vitro studies to human disease, where
possible, we should utilize systems more accurately reflecting the
cellular complexity of atherosclerosis. One limitation that must
be noted is the lack of cell contact, which would be experienced
by these cells in the vessel. However, even in the absence of
these interactions, clear phenotypic differences in ECs and SMCs
from triple vs. double-cell 2D cultures were observed. In addition,
when using 0.4µmpored inserts it would not be possible to study
transmigration of immune cells thorough both the endothelial
and smooth muscle layer, though studying cell adhesion would
be possible. Whilst the model presented utilized THP-1 cells as
the immune compartment, the use of PBMCs, or other immune
cell populations, would be a highly useful extrapolation of our
data. Ultimately, our aim was not to develop one system, but to
provide a framework which could be adapted for specific immune
and vascular cells of interest.
The main utility of this model is the ability to isolate each
cellular compartment without cell sorting in order to carry out
classical molecular analyses similar to those conducted in this
study. We would suggest that this triple-cell 2D model would
be highly useful for studying the impact of key inflammatory
mediators and atherogenic stimuli at the molecular level whilst
retaining the important biological influence of immune and
vascular cell communication in a simple and robust manner.
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